Zobrazeno 1 - 10
of 127
pro vyhledávání: '"James C. Sisson"'
Publikováno v:
Thyroid. 22:430-436
Three endocrine neoplasms-bilateral pheochromocytomas, somatotrophic pituitary adenoma inducing acromegaly, and papillary carcinoma of the thyroid-occurred concurrently in a patient. A genetic mutation was hypothesized. Possible previously described
Autor:
Huan T. Ha, James C. Sisson, Susan G. Urba, Ronald J. Koenig, Francis P. Worden, Thomas J. Giordano, Julia S. Lee
Publikováno v:
Thyroid. 20:975-980
Currently, there is no standard treatment for metastatic anaplastic thyroid cancer (ATC). DNA microarray analysis has shown platelet-dervived growth factor receptor (PDGFR) overexpression in ATC relative to well-differentiated thyroid cancer. In p53-
Publikováno v:
Head & Neck. 31:689-694
Background. The hereditary paraganglioma syn- dromes (PGLs) are autosomal dominant conditions with an increased risk for tumors of the sympathetic and parasympathetic neuroendocrine systems. The recognition of patients with heredi- tary PGL and ident
Publikováno v:
Thyroid. 19:297-303
Infringement by differentiated thyroid carcinoma on the brain is rare but, when suspected, the patient deserves special attention. A patient with an enlarging metastasis of thyroid carcinoma to the skull that was impinging on the brain illustrates di
Publikováno v:
Annals of the New York Academy of Sciences. 1073:505-511
Survival of patients with metastatic pheochromocytoma that have exceeded 30 years without therapy to reduce tumors have been reported. We reviewed the records of 38 patients with malignant pheochromocytoma who had received 131I-metaiodiobenzylguanidi
Publikováno v:
Clinical Nuclear Medicine. 31:5-8
Purpose: This article describes a patient with dual radiation-induced malignancies after treatment of neuroblastoma. Materials and Methods: A 12-year-old boy with a history of neuroblastoma was treated with chemotherapy, 1-131 MIBG, and radiotherapy
Autor:
James C. Sisson, Judiann Miskulin, Gerard M. Doherty, Paul G. Gauger, Richard E. Burney, Barry L. Shulkin
Publikováno v:
Surgery. 134:918-922
Background Iodine 123 meta-iodobenzylguanidine (MIBG) scintigraphy has been used in patients with clinical suspicion of pheochromocytoma to confirm the nature of an adrenal or extraadrenal mass or to identify occult disease. Additionally, it may be u
Autor:
James C. Sisson
Publikováno v:
Annals of the New York Academy of Sciences. 970:54-60
Malignant pheochromocytomas, a group of tumors that include metastatic paragangliomas, often produce hypertension and episodic symptoms from secretion of norepinephrine and sometimes epinephrine. In addition, the tumors usually manifest progressive m
Autor:
James C. Sisson
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 17:101-105
Radioiodine treatments of patients with well-differentiated thyroid carcinoma have generally been safe and beneficial. Safety can be ensured while efficacy is increased through practical methods of dosimetry that measure body retention of 131I. Presc
Publikováno v:
Thyroid. 10:165-169
We hypothesized that elevated levels of serum thyroglobulin (Tg) are frequently found as the only index of residual neoplasm in patients with low-risk papillary thyroid carcinoma. The records of patients operated on for papillary thyroid carcinoma ov